Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency.

IMPORTANCE Proton pump inhibitors (PPIs) and histamine 2 receptor antagonists (H2RAs) suppress the production of gastric acid and thus may lead to malabsorption of vitamin B12. However, few data exist regarding the associations between long-term exposure to these medications and vitamin B12 deficiency in large population-based studies. OBJECTIVE To study the association between use of PPIs and H2RAs and vitamin B12 deficiency in a community-based setting in the United States. DESIGN, SETTING, AND PATIENTS We evaluated the association between vitamin B12 deficiency and prior use of acid-suppressing medication using a case-control study within the Kaiser Permanente Northern California population. We compared 25,956 patients having incident diagnoses of vitamin B12 deficiency between January 1997 and June 2011 with 184,199 patients without B12 deficiency. Exposures and outcomes were ascertained via electronic pharmacy, laboratory, and diagnostic databases. MAIN OUTCOMES AND MEASURES Risk of vitamin B12 deficiency was estimated using odds ratios (ORs) from conditional logistic regression. RESULTS Among patients with incident diagnoses of vitamin B12 deficiency, 3120 (12.0%) were dispensed a 2 or more years' supply of PPIs, 1087 (4.2%) were dispensed a 2 or more years' supply of H2RAs (without any PPI use), and 21,749 (83.8%) had not received prescriptions for either PPIs or H2RAs. Among patients without vitamin B12 deficiency, 13,210 (7.2%) were dispensed a 2 or more years' supply of PPIs, 5897 (3.2%) were dispensed a 2 or more years' supply of H2RAs (without any PPI use), and 165,092 (89.6%) had not received prescriptions for either PPIs or H2RAs. Both a 2 or more years' supply of PPIs (OR, 1.65 [95% CI, 1.58-1.73]) and a 2 or more years' supply of H2RAs (OR, 1.25 [95% CI, 1.17-1.34]) were associated with an increased risk for vitamin B12 deficiency. Doses more than 1.5 PPI pills/d were more strongly associated with vitamin B12 deficiency (OR, 1.95 [95% CI, 1.77-2.15]) than were doses less than 0.75 pills/d (OR, 1.63 [95% CI, 1.48-1.78]; P = .007 for interaction). CONCLUSIONS AND RELEVANCE Previous and current gastric acid inhibitor use was significantly associated with the presence of vitamin B12 deficiency. These findings should be considered when balancing the risks and benefits of using these medications.

[1]  A. B. Hill.  The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.

[2]  R. Valuck,et al.  A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults. , 2004, Journal of clinical epidemiology.

[3]  C. Beyan,et al.  Helicobacter pylori--is it a novel causative agent in Vitamin B12 deficiency? , 2000, Archives of internal medicine.

[4]  M. Bachem,et al.  Serum Iron, Ferritin, and Vitamin B12 During Prolonged Omeprazole Therapy , 1992, Journal of clinical gastroenterology.

[5]  S. Shoor,et al.  Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study , 2005, The Lancet.

[6]  J. Grigsby,et al.  High Prevalence of Cobalamin Deficiency in Elderly Outpatients , 1992, Journal of the American Geriatrics Society.

[7]  H. Morgenstern,et al.  Epidemiologic Research: Principles and Quantitative Methods. , 1983 .

[8]  S. Meuwissen,et al.  Effect of short‐ and long‐term treatment with omeprazole on the absorption and serum levels of cobalamin , 1996, Alimentary pharmacology & therapeutics.

[9]  K. Chow,et al.  Risk factors of vitamin B(12) deficiency in patients receiving metformin. , 2006, Archives of internal medicine.

[10]  B. Hirschowitz,et al.  Vitamin B12 deficiency in hypersecretors during long‐term acid suppression with proton pump inhibitors , 2008, Alimentary pharmacology & therapeutics.

[11]  S. le Cessie,et al.  Long‐term use of proton pump inhibitors and vitamin B12 status in elderly individuals , 2008, Alimentary pharmacology & therapeutics.

[12]  P. Menheere,et al.  Are Children with Cystic Fibrosis Who Are Treated With a Proton-Pump Inhibitor at Risk for Vitamin B 12 Deficiency? , 2001, Journal of pediatric gastroenterology and nutrition.

[13]  M. Baker,et al.  Pernicious anemia. , 1947, American practitioner and digest of treatment.

[14]  N. Krieger.  Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. , 1992, American journal of public health.

[15]  E. Norkus,et al.  Do acid-lowering agents affect vitamin B12 status in older adults? , 2008, Journal of the American Medical Directors Association.

[16]  Ataullah Khan,et al.  Vitamin B12 deficiency common in primary hypothyroidism. , 2008, JPMA. The Journal of the Pakistan Medical Association.

[17]  P. Wilson,et al.  Prevalence of cobalamin deficiency in the Framingham elderly population. , 1994, The American journal of clinical nutrition.

[18]  D. Albanes,et al.  Effects of moderate alcohol consumption on folate and vitamin B12 status in postmenopausal women , 2004, European Journal of Clinical Nutrition.

[19]  P. Khazanie,et al.  Omeprazole Therapy Causes Malabsorption of Cyanocobalamin (Vitamin B12) , 1994, Annals of Internal Medicine.

[20]  E. Cook,et al.  Validation of a beta-agonist long-term asthma control scale derived from computerized pharmacy data. , 2006, The Journal of allergy and clinical immunology.

[21]  David W. Hosmer,et al.  Applied Logistic Regression , 1991 .

[22]  L. Braverman,et al.  Prevalence and Evaluation of B12 Deficiency in Patients with Autoimmune Thyroid Disease , 2006, The American journal of the medical sciences.

[23]  R. Russell,et al.  Effect of hypochlorhydria due to omeprazole treatment or atrophic gastritis on protein-bound vitamin B12 absorption. , 1994, Journal of the American College of Nutrition.

[24]  V. Tolia,et al.  Long-Term Proton Pump Inhibitor Use in Children: A Retrospective Review of Safety , 2008, Digestive Diseases and Sciences.

[25]  R. Topolski,et al.  The Prevalence of Vitamin B12 Deficiency in Patients with Type 2 Diabetes: A Cross-Sectional Study , 2009, The Journal of the American Board of Family Medicine.

[26]  R. Jensen,et al.  Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome. , 1998, The American journal of medicine.

[27]  Sander Greenland,et al.  Modern Epidemiology 3rd edition , 1986 .

[28]  N. Breslow,et al.  Statistical methods in cancer research: volume 1- The analysis of case-control studies , 1980 .

[29]  R. Allen,et al.  Vitamin B-12 deficiency in the elderly: current dilemmas. , 1997, The American journal of clinical nutrition.

[30]  N. Breslow,et al.  Statistical methods in cancer research. Vol. 1. The analysis of case-control studies. , 1981 .

[31]  E. Podell,et al.  Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. , 1988, The New England journal of medicine.

[32]  M. Desai,et al.  Effect of Vegetarianism and Smoking on Vitamin B12, Thiocyanate, and Folate Levels in the Blood of Normal Subjects , 1972, British medical journal.